
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Cancer Research, Vol 1, Issue 11 1245-1251, Copyright © 1995 by American Association for Cancer Research
ARTICLES |
H Tahara, H Kuniyasu, H Yokozaki, W Yasui, JW Shay, T Ide and E Tahara
Department of Cellular and Molecular Biology and First Department of Pathology, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-Ku, Hiroshima 734, Japan.
Recent evidence indicates that telomerase activity may be necessary for cell immortality, which is required for the sustained and indefinite growth of most malignant cells. We analyzed telomerase activity in gastric and colorectal cancers and in gastric and colorectal precancerous lesions to determine whether malignant progression depends on the activation of telomerase and at what stage of carcinogenesis cells have detectable telomerase activity. Telomerase activity was measured by the telomeric repeat amplification protocol assay and was detected in 17 (85%) of 20 primary gastric carcinoma tissues and in 19 (95%) of 20 primary colorectal carcinomas, regardless of tumor staging and histological types. All nodal metastases, peritoneal metastases, and a recurrent gastric cancer tumor were positive. All cell lines established from gastric and colorectal cancers contained telomerase activity. In precancerous lesions, 10 (100%) of 10 colorectal tubular adenomas were telomerase positive, in addition to 3 (23%) of 13 gastric intestinal metaplasias and 1 (50%) of 2 gastric adenomas, whereas the corresponding gastric normal mucosas as well as colorectal mucosas were negative. These results indicate overall that reactivation of telomerase may occur at an early stage of carcinogenesis and may correlate well with malignant progression of gastric cancer. Telomerase activity thus may serve as a powerful additional tool for cancer diagnosis.
This article has been cited by other articles:
![]() |
G. Capella, G. Pera, N. Sala, A. Agudo, F. Rico, G. Del Giudicce, M. Plebani, D. Palli, H. Boeing, H B. Bueno-de-Mesquita, et al. DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study Int. J. Epidemiol., July 19, 2008; (2008) dyn145v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kondo, N. Oue, K. Yoshida, Y. Mitani, K. Naka, H. Nakayama, and W. Yasui Expression of POT1 is Associated with Tumor Stage and Telomere Length in Gastric Carcinoma Cancer Res., January 15, 2004; 64(2): 523 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakanishi, T. Kawai, F. Kumaki, S. Hiroi, M. Mukai, E. Ikeda, C. E. Koering, and E. Gilson Expression of mRNAs for Telomeric Repeat Binding Factor (TRF)-1 and TRF2 in Atypical Adenomatous Hyperplasia and Adenocarcinoma of the Lung Clin. Cancer Res., March 1, 2003; 9(3): 1105 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tatsumoto, E. Hiyama, Y. Murakami, Y. Imamura, J. W. Shay, Y. Matsuura, and T. Yokoyama High Telomerase Activity Is an Independent Prognostic Indicator of Poor Outcome in Colorectal Cancer Clin. Cancer Res., July 1, 2000; 6(7): 2696 - 2701. [Abstract] [Full Text] |
||||
![]() |
B. Heine, S. E Coupland, S. Kneiff, G. Demel, N. Bornfeld, M. Hummel, and H. Stein Telomerase expression in uveal melanoma Br. J. Ophthalmol., February 1, 2000; 84(2): 217 - 223. [Abstract] [Full Text] |
||||
![]() |
B.-S. Herbert, A. E. Pitts, S. I. Baker, S. E. Hamilton, W. E. Wright, J. W. Shay, and D. R. Corey Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death PNAS, December 7, 1999; 96(25): 14276 - 14281. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Ohyashiki, H. Iwama, N. Yahata, K. Ando, S. Hayashi, J. W. Shay, and K. Ohyashiki Telomere Stability Is Frequently Impaired in High-Risk Groups of Patients with Myelodysplastic Syndromes Clin. Cancer Res., May 1, 1999; 5(5): 1155 - 1160. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hirose, J. Abe-Hashimoto, H. Tahara, T. Ide, and T. Yoshimura New method to measure telomerase activity by transcription-mediated amplification and hybridization protection assay Clin. Chem., December 1, 1998; 44(12): 2446 - 2452. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Banerjee, S. Banerjee, B. R. Zirkin, and T. R. Brown Telomerase Activity in Normal Adult Brown Norway Rat Seminal Vesicle: Regional Distribution and Age-Dependent Changes Endocrinology, March 1, 1998; 139(3): 1075 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Banerjee, S. Banerjee, B. R. Zirkin, and T. R. Brown Lobe-Specific Telomerase Activity in the Intact Adult Brown Norway Rat Prostate and Its Regional Distribution within the Prostatic Ducts Endocrinology, February 1, 1998; 139(2): 513 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Belair, T. R. Yeager, P. M. Lopez, and C. A. Reznikoff Telomerase activity: A biomarker of cell proliferation, not malignant transformation PNAS, December 9, 1997; 94(25): 13677 - 13682. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |